GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer

Neoadjuvant chemoradiotherapy (nCRT) combined with surgery is a standard therapy for locally advanced rectal cancer (LARC). The aim of this study was to assess the expression of GOLPH3 (Golgi phosphoprotein 3), a newly found oncogene, in LARC as well as its relationship with nCRT sensitivity and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Kunli, Zhao, Qianqian, Yue, Jinbo, Shi, Pengyue, Yan, Hongjiang, Xu, Xiaoqing, Wang, Renben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356558/
https://www.ncbi.nlm.nih.gov/pubmed/27634904
http://dx.doi.org/10.18632/oncotarget.12008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356558/
https://www.ncbi.nlm.nih.gov/pubmed/27634904
http://dx.doi.org/10.18632/oncotarget.12008

Ejemplares similares